Adial Pharmaceuticals, Inc. (ADIL) — 分析师展望 / 分析师共识目标价为. 基于 3 位分析师评级, 共识为 看涨 — 3 买入.
分析师共识目标价为 $8.00, 上涨空间为 393.8% 相对于当前价格 $1.62.
分析师预估 每股收益(EPS)为 $-69.38 和 营收为 $0.00B (下一财年).
每股收益(EPS)历史表现: 2024: 实际 $-0.71 vs 预期 $-69.38 (超预期 +99%). 2025: 实际 $-11.93 vs 预期 $-11.11 (不及预期 -7.4%). 分析师准确度: 0%.
ADIL 股票 — 12个月价格预测
$8.00
▲ +393.83% 上涨空间
平均目标价
Based on 3 Wall Street analysts offering 12-month price targets for Adial Pharmaceuticals, Inc., the price target is $8.00.
平均目标价相对最新价格 $1.62 变动 +393.83%。
ADIL 分析师评级
Buy
基于过去3个月内 3 位分析师对 Adial Pharmaceuticals, Inc. 的评级
EPS 预测 — ADIL
0%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024
Actual –$0.71
vs Est –$69.38
▲ 9,671.1% off
2025
Actual –$11.93
vs Est –$11.11
▼ 6.9% off
Profitability Outlook
Company has been making losses in all recent fiscal years. Analysts expect losses to continue near-term.
营收预测 — ADIL
Revenue Trend
Revenue has been relatively flat. Analysts expect stable revenue going forward.
